BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9833702)

  • 1. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder.
    Misra V; Mukherjee J; Gupta SC; Tandon S; Gupta AK
    APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
    Johnson GC; Miller MA; Ramos-Vara JA
    J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions in transitional cell tumors of the bladder.
    Cairns P; Suarez V; Newman J; Crocker J
    Arch Pathol Lab Med; 1989 Nov; 113(11):1250-2. PubMed ID: 2479357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on nucleolar organizer regions in bladder neoplasm].
    Takeuchi T
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1711-9. PubMed ID: 2287118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
    Helpap B; Loesevitz L; Bulatko A
    Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
    Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
    Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations of nucleoli and nucleolar organizers in proliferative cystitis and transitional cell carcinoma of the urinary bladder].
    Romanenko AM; Nosov AT; Bazalitskaia SV; Sabri Abdel' Maliak S; Adne ZhZh
    Arkh Patol; 1992; 54(7):14-20. PubMed ID: 1471934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
    Mansour P; Crocker J; Newman J
    Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of AgNOR analysis of urothelial carcinomas].
    Helpap B; Loesevitz L
    Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AgNOR/P53 expression compared with different grades in bladder carcinoma.
    Karakök M; Aydin A; Bakir K; Uçak R; Korkmaz C
    Int Urol Nephrol; 2001; 33(2):353-5. PubMed ID: 12092655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
    Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
    Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue stroma in bladder papillary transitional cell carcinoma, carcinoma in situ and benign cystitis.
    Ooms EC; Blomjous CE; Zwartendijk J; Veldhuizen RW; Blok AP; Heinhuis RJ; Boon ME
    Histopathology; 1986 Jun; 10(6):613-9. PubMed ID: 2426175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of the nucleolar organizer regions to urinary cytology and its computer-assisted image analysis].
    Takeuchi T; Nagatani Y; Tada K; Sugiyama S; Koide T; Sakai S; Tanaka T; Mori H; Yamamoto N; Kobayashi S
    Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1494-503. PubMed ID: 1942708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice.
    Iwata H; Otoshi T; Takada N; Murai T; Tamano S; Watanabe T; Katsura Y; Fukushima S
    Urol Res; 1995; 23(1):27-32. PubMed ID: 7618232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ; Nordling S
    Br J Cancer; 1991 Dec; 64(6):1139-44. PubMed ID: 1764378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.